8-K: Quipt Home Medical Reports Q1 Fiscal Year 2025 Financial Results, Shows Improvement in Adjusted EBITDA

Quipt Home Medical Corp. announces its Q1 2025 financial results, highlighting a sequential improvement in Adjusted EBITDA despite a slight revenue decrease.

Summary

• Quipt Home Medical Corp. reported its Q1 fiscal year 2025 financial results, with the period ending December 31, 2024.
• Revenue for Q1 2025 was $61.4 million, a 2% decrease compared to $62.6 million in Q1 2024, but flat compared to Q4 2024.
• The discontinuation of the Medicare 75/25 blended rate, Medicare Advantage member withdrawals, and a non-renewed disposable supply contract had a cumulative annual impact of approximately $8.0 million.
• Net loss improved to ($1.1) million, or ($0.03) per diluted share, compared to ($1.5) million, or ($0.04) per diluted share, in Q1 2024.
• Cash flow from operations was $9.3 million for Q1 2025, down from $10.6 million in Q1 2024.
• The company had $15.5 million in cash on hand as of December 31, 2024, and total credit availability of $32.4 million.
• Recurring revenue remained strong at 77% of total revenue.
• Adjusted EBITDA for Q1 2025 was $14.0 million (22.8% of revenue), compared to $15.3 million (24.5% of revenue) for Q1 2024, but sequentially increased by 4.5% from Q4 2024.
• The Net Debt to Adjusted EBITDA Leverage Ratio is 1.5.
• The company served approximately 157,000 unique patients in Q1 2025, a 1% increase year-over-year.
• The company completed approximately 221,000 unique set-ups/deliveries in Q1 2025, a 3% increase compared to approximately 215,000 in Q1 2024.
• The resupply program now consists of 174,000 patients for the twelve months ended December 31, 2024, compared to 172,000 patients for the twelve months ended September 30, 2024.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive. While revenue is down slightly, the company is showing improved profitability and a focus on efficiency. The management commentary is optimistic about future growth.

Positives

• Net loss improved compared to the same quarter last year, decreasing from ($1.5) million to ($1.1) million.
• Adjusted EBITDA sequentially increased by 4.5% from the previous quarter.
• Recurring revenue remains strong at 77% of total revenue, indicating a stable revenue base.
• The company's customer base increased by 1% year-over-year.
• The company completed approximately 221,000 unique set-ups/deliveries in Q1 2025, a 3% increase year-over-year.

Negatives

• Revenue decreased by 2% compared to the same quarter last year, from $62.6 million to $61.4 million.
• Cash flow from operations decreased from $10.6 million to $9.3 million year-over-year.
• Adjusted EBITDA decreased from $15.3 million to $14.0 million year-over-year.

Risks

• The discontinuation of the Medicare 75/25 blended rate negatively impacted revenue and operating results.
• Withdrawal of Medicare Advantage members due to capitated agreements with other providers affected revenue.
• The non-renewal of a disposable supply contract further contributed to revenue reduction.
• The company is subject to risks related to credit, market, liquidity, operational, reputational, insurance, strategic, regulatory, legal, environmental, and capital adequacy.
• The company is subject to risks related to cyber-attacks on the Company's information technology, internet, network access or other voice or data communications systems or services.

Future Outlook

The company anticipates strong margin performance throughout the year and a return to historical organic growth levels in calendar 2025. They are focused on expanding their presence in existing and new markets and leveraging their scalable business platform to broaden their product offerings and service reach.

Management Comments

• Gregory Crawford, Chairman and CEO, stated that the results reflect progress in strengthening operations and positioning the business for long-term growth.
• Hardik Mehta, CFO, noted that operational enhancements are enabling the company to operate more efficiently while maintaining high-quality patient care.

Industry Context

Quipt operates in the home medical equipment (HME) sector, which is influenced by factors such as reimbursement rates, technological advancements, and demographic trends. The company's focus on respiratory care and chronic disease management aligns with the increasing demand for in-home healthcare services.

Comparison to Industry Standards

• It's difficult to provide a precise comparison without knowing Quipt's specific market segments and competitive landscape.
• However, generally, HME companies like AdaptHealth, Rotech Healthcare, and Lincare Holdings are key players.
• Quipt's Adjusted EBITDA margin of 22.8% is a key metric to compare against these companies, as well as revenue growth and recurring revenue percentage.
• A strong recurring revenue base of 77% is generally considered positive in the HME industry, indicating customer retention and stability.

Stakeholder Impact

• Shareholders may see potential for long-term growth and value creation.
• Employees may experience changes due to organizational restructuring and efficiency improvements.
• Patients should continue to receive high-quality care.
• Suppliers may see consistent demand for products and services.

Next Steps

• The company will continue to optimize its organizational structure.
• The company will enhance operational efficiencies by reducing redundancies.
• The company will centralize back-office processes.
• The company will explore and pursue all avenues to drive shareholder value.

Key Dates